These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 360247)

  • 41. Anxiety does not predict response to antidepressant treatment in late life depression: results of a meta-analysis.
    Nelson JC; Delucchi K; Schneider LS
    Int J Geriatr Psychiatry; 2009 May; 24(5):539-44. PubMed ID: 19334041
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A double blind cross over comparison of RO5-3350, bromazepam, diazepam (valium) and chlordiazepoxide (librium) in the treatment of neurotic anxiety.
    Kerry RJ; Jenner FA; Pearson IB
    Psychosomatics; 1972; 13(2):122-4. PubMed ID: 4604001
    [No Abstract]   [Full Text] [Related]  

  • 43. Compliance and improvement in drug-treated and placebo-treated neurotic outpatients.
    Rickels K; Downing R
    Arch Gen Psychiatry; 1966 Jun; 14(6):631-3. PubMed ID: 5327339
    [No Abstract]   [Full Text] [Related]  

  • 44. Management of psychoneurotic anxiety and depression in outpatients.
    McLaughlin B
    Psychosomatics; 1969; 10(3):28-31. PubMed ID: 4898443
    [No Abstract]   [Full Text] [Related]  

  • 45. Melperone in low doses in anxious neurotic patients. A double-blind placebo-controlled clinical study.
    Pöldinger WJ
    Neuropsychobiology; 1984; 11(3):181-6. PubMed ID: 6147789
    [TBL] [Abstract][Full Text] [Related]  

  • 46. DOUBLE BLIND STUDY WITH DIAZEPAM, CHLORDIAZEPOXIDE AND PLACEBO IN THE TREATMENT OF PSYCHONEUROTIC ANXIETY.
    DANEMAN EA
    J Med Assoc Ga; 1964 Feb; 53():55-8. PubMed ID: 14256274
    [No Abstract]   [Full Text] [Related]  

  • 47. Chlormezanone in anxiety: a drug rediscovered?
    Rickels K; Pereira-Ogan JA; Case WG; Csanalosi I; Mirman MJ; Nathanson JE; Parish LC
    Am J Psychiatry; 1974 May; 131(5):592-5. PubMed ID: 4594560
    [No Abstract]   [Full Text] [Related]  

  • 48. Halazepam and diazepam in neurotic anxiety: a double-blind study.
    Rickels K; Pereira-Organ J; Csanalosi I; Morris RJ; Rosenfeld H; Sablosky L; Schless A; Werblowsky JH
    Psychopharmacology (Berl); 1977 Apr; 52(2):129-36. PubMed ID: 18749
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug, doctor warmth, and clinic setting in the symptomatic response to minor tranquilizers.
    Rickels K; Lipman RS; Park LC; Covi L; Uhlenhugh EH; Mock JE
    Psychopharmacologia; 1971; 20(2):128-52. PubMed ID: 4933093
    [No Abstract]   [Full Text] [Related]  

  • 50. The efficacy and safety of nabilone (a synthetic cannabinoid) in the treatment of anxiety.
    Fabre LF; McLendon D
    J Clin Pharmacol; 1981; 21(S1):377S-382S. PubMed ID: 6117575
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective short-term treatment of generalized anxiety disorder with trifluoperazine.
    Mendels J; Krajewski TF; Huffer V; Taylor RJ; Secunda S; Schless A; Sebastian JA; Semchyshyn G; Durr MJ; Melmed AS
    J Clin Psychiatry; 1986 Apr; 47(4):170-4. PubMed ID: 3514583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Drug- and placebo-treated neurotic outpatients. Pretreatment levels of manifest anxiety, clinical improvement, and side reactions.
    Rickels K; Downing RW
    Arch Gen Psychiatry; 1967 Mar; 16(3):269-72. PubMed ID: 6021472
    [No Abstract]   [Full Text] [Related]  

  • 53. An adrenergic drug in depression.
    Wheatley D
    Arch Gen Psychiatry; 1975 May; 32(5):653-5. PubMed ID: 1092284
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative effects of propranolol and chlordiazepoxide in anxiety states.
    Wheatley D
    Br J Psychiatry; 1969 Dec; 115(529):1411-2. PubMed ID: 4902187
    [No Abstract]   [Full Text] [Related]  

  • 55. The use of self-rating scales in a single-patient multiple cross-over trial.
    Kellner R; Sheffield BF
    Br J Psychiatry; 1968 Feb; 114(507):193-6. PubMed ID: 4867804
    [No Abstract]   [Full Text] [Related]  

  • 56. Early placebo response in anxious and depressed patients.
    Loebel AD; Hyde TS; Dunner DL
    J Clin Psychiatry; 1986 May; 47(5):230-3. PubMed ID: 3516977
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benzodiazepines in the treatment of aggressive patients.
    Lion JR
    J Clin Psychiatry; 1979 Feb; 40(2):70-1. PubMed ID: 762032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Some effects of chlordiazepoxide and meprobamate with psychiatric outpatients.
    McNair DM; Goldstein AP; Lorr M; Cibelli LA; Roth I
    Psychopharmacologia; 1965 Mar; 7(4):256-65. PubMed ID: 5319123
    [No Abstract]   [Full Text] [Related]  

  • 59. The treatment of mixed anxiety and depression with loxapine: a controlled comparative study.
    Brauzer B; Goldstein BJ; Steinbook RM; Jacobson AF
    J Clin Pharmacol; 1974; 14(8):455-63. PubMed ID: 4605350
    [No Abstract]   [Full Text] [Related]  

  • 60. Anxiety in schizophrenia. The responses to chlordiazepoxide in an intensive design study.
    Kellner R; Wilson RM; Muldawer MD; Pathak D
    Arch Gen Psychiatry; 1975 Oct; 32(10):1246-54. PubMed ID: 241306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.